DaVita HealthCare (DVA) closed at $164.82, up 0.15%, but underperformed the S&P 500's 0.47% gain. The company is set to announce earnings on October 29, 2024, with an expected EPS of $2.76, a 3.16% decline year-over-year, while revenue is projected to grow by 3.23% to $3.22 billion. Currently, DaVita holds a Zacks Rank of #2 (Buy) and trades at a Forward P/E of 16.48, significantly lower than the industry average of 25.1.